1. Baumgartner AM, Jones PF, Baumgartner WA, Black CT. Radioimmunoassay of hair for determining opiate-abuse histories. J Nucl Med 1979;20:748-752.

2. Kintz P. Value of hair analysis in postmortem toxicology. Forensic Sci Int 2004;142:127-134.

3. Proposed revisions to mandatory guidelines for federal workplace drug testing programs. Substance abuse and mental health services administration. Federal Register vol. 69 no. 71, April 13, 2004, 19673-732.

4. Harrison WH, Gray RM, Solomon LM. Incorporation of D-amphetamine into pigmented guinea-pig hair. Br J Dermatol 1974;91:415-418.

5. Nakahara Y. Detection and diagnostic interpretation of amphetamines in hair. Forensic Sci Int 1995;70:135-153.

6. Vinner E, Vignau J, Thibault D, Codaccioni X, Brassart C, Humbert L, et al. Hair analysis of opiates in mothers and newborns for evaluating opiate exposure during pregnancy. Forensic Sci Int 2003;133:57-62.

7. Takayama N, Iio R, Tanaka S, Chinaka S, Hayakawa K. Analysis of methamphetamine and its metabolites in hair. Biomed Chromatogr 2003;17:74-82.

8. Sweeney SA, Kelly RC, Bourland JA, Johnson T, Brown WC, Lee H, et al. Amphetamines in hair by enzyme-linked immunosorbent assay. J Anal Toxicol 1998;22:418-424.

9. Quintela O, Bermejo AM, Tabernero MJ, Strano-Rossi S, Chiarotti M, Lucas AC. Evaluation of cocaine, amphetamines and cannabis use in university students through hair analysis: preliminary results. Forensic Sci Int 2000;107:273-279.

10. Miki A, Katagi M, Tsuchihashi H. Application of EMIT d.a.u. for the semiquantitative screening of methamphetamine incorporated in hair. J Anal Toxicol 2002;26:274-279.

11. Rothe M, Prägst F, Spiegel K, Harrach T, Fischer K, Kunkel J. Hair concentrations and self-reported abuse history of 20 amphetamine and ecstasy users. Forensic Sci Int 1997;89:111-128.

12. Cooper GA, Allen DL, Scott KS, Oliver JS, Ditton J, Smith ID. Hair analysis: self-reported use of "speed" and "ecstasy" compared with laboratory findings. J Forensic Sci 2000;45:400-406.

13. Koide I, Noguchi O, Okada K, Yokoyama A, Oda H, Yamamoto S, et al. Determination of amphetamine and methamphetamine in human hair by headspace solid-phase microextraction and gas chromatography with nitrogen-phosphorus detection. J Chromatogr B Biomed Sci Appl 1998;707:99-104.

14. Kintz P, Cirimele V, Mangin P. Testing human hair for cannabis. II. Identification of THC-COOH by GC-MS-NCI as a unique proof. J Forensic Sci 1995;40:619-622.

15. Wilkins D, Haughey H, Cone E, Huestis M, Foltz R, Rollins D. Quantitative analysis of THC, 11-OH-THC, and THCCOOH in human hair by negative ion chemical ionization mass spectrometry. J Anal Toxicol 1995;19:483-491.

16. Kim JY, Suh SI, In MK, Paeng KJ, Chung BC. Simultaneous determination of cannabidiol, cannabinol, and delta9-tetrahydrocannabinol in human hair by gas chromatography-mass spectrometry. Arch Pharm Res 2005;28:1086-1091.

17. Marsili R, Martello S, Felli M, Fiorina S, Chiarotti M. Hair testing for delta9-THC-COOH by gas chromatography/tandem mass spectrometry in negative chemical ionization mode. Rapid Commun Mass Spectrom 2005;19:1566-1568.

18. Baptista MJ, Monsanto PV, Pinho Marques EG, Bermejo A, Avila S, Castanheira AM, et al. Hair analysis for delta(9)-THC, delta(9)-THC-COOH, CBN and CBD, by GC/MS-EI. Comparison with GC/MS-NCI for delta(9)-THC-COOH. Forensic Sci Int 2002;128:66-78.

19. Backofen U, Matysik FM, Lunte CE. Determination of cannabinoids in hair using high-pH* non-aqueous electrolytes and electrochemical detection. Some aspects of sensitivity and selectivity. J Chromatogr A 2002;942:259-269.

20. Moore C, Guzaldo F, Donahue T. The determination of 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid (THC-COOH) in hair using negative ion gas chromatography-mass spectrometry and high-volume injection. J Anal Toxicol 2001;25:555-558.

21. Sachs H, Dressler U. Detection of THCCOOH in hair by MSD-NCI after HPLC clean-up. Forensic Sci Int 2000;107:239-247.

22. Baumgartner WA, Black CT, Jones PF, Blahd WH. Radioimmunoassay of cocaine in hair: concise communication. J Nucl Med 1982;23:790-792.

23. Schaffer MI, Wang WL, Irving J. An evaluation of two wash procedures for the differentiation of external contamination versus ingestion in the analysis of human hair samples for cocaine. J Anal Toxicol 2002;26:485-488.

24. Graham K, Koren G, Klein J, Schneiderman J, Greenwald M. Determination of gestational cocaine exposure by hair analysis. JAMA 1989;262:3328-3330.

25. Katikaneni LD, Salle FR, Hulsey TC. Neonatal hair analysis for benzoylecgonine: a sensitive and semiquantitative biological marker for chronic gestational cocaine exposure. Biol Neonate 2002;81:29-37.

26. Felli M, Martello S, Marsili R, Chiarotti M. Disappearance of cocaine from human hair after abstinence. Forensic Sci Int 2005;154:96-98.

27. Bermejo AM, Lopez P, Alvarez I, Tabernero MJ, Fernandez P. Solid-phase microextraction for the determination of cocaine and cocaethylene in human hair by gas chromatography-mass spectrometry. Forensic Sci Int 2006;156:2-8.

28. Cognard E, Rudaz S, Bouchonnet S, Staub C. Analysis of cocaine and three of its metabolites in hair by gas chromatography-mass spectrometry using ion-trap detection for CI/MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2005;826:17-25.

29. Kintz P, Bundeli P, Brenneisen R, Ludes B. Dose-concentration relationships in hair from subjects in a controlled heroin-maintenance program. J Anal Toxicol 1998;22:231-236.

30. Jones J, Tomlinson K, Moore C. The simultaneous determination of codeine, morphine, hydrocodone, hydromorphone, 6-acetylmorphine, and oxycodone in hair and oral fluid. J Anal Toxicol 2002;26:171-175.

31. Gambelunghe C, Rossi R, Ferranti C, Bacci M. Hair analysis by GC/MS/MS to verify abuse of drugs. J Appl Toxicol 2005;25:205-211.

32. Lachenmeier K, Musshoff F, MadeaB. Determination of opiates and cocaine in hair using automated enzyme immunoassay screening methodologies followed by gas chromatographic-mass spectrometric (GC-MS) confirmation. Forensic Sci Int 2006;159:189-199.

33. Cooper G, Wilson L, Reid C, Baldwin D, Hand C, Spiehler V. Validation of the Cozart microplate ELISA for detection of opiates in hair. J Anal Toxicol 2003;27:581-586.

34. Baumgartner AM, Jones PF, Black CT. Detection of phencyclidine in hair. J Forensic Sci 1981;26:576-581.

35. Sramek JJ, Baumgartner WA, Tallos JA, Ahrens TN, Heiser JF, Blahd WH. Hair analysis for detection of phencyclidine in newly admitted psychiatric patients. Am J Psychiatry 1985;142:950-953.

36. Swartz MS, Swanson JW, Hannon MJ. Detection of illicit substance use among persons with schizophrenia by radioimmunoassay of hair. Psychiatr Serv 2003;54:891-895.

37. Borges CR, Wilkins DG, Rollins DE. Amphetamine and N-acetylamphetamine incorporation into hair: an investigation of the potential role of drug basicity in hair color bias. J Anal Toxicol 2001;25:221-227.

38. Kronstrand R, Ahlner J, Dizdar N, Larson G. Quantitative analysis of desmethylselegiline, metham-phetamine, and amphetamine in hair and plasma from Parkinson patients on long-term selegiline medication. J Anal Toxicol 2003;27:135-141.

39. Reid RW, O'Connor FL, Crayton JW. The in vitro differential binding of benzoylecgonine to pigmented human hair samples. J Toxicol Clin Toxicol 1994;32:405-410.

40. Ursitti F, Klein J, Sellers E, Koren G. Use of hair analysis for confirmation of self-reported cocaine use in users with negative urine tests. J Toxicol Clin Toxicol 2001;39:361-366.

41. Goldberger BA, Darraj AG, Caplan YH, Cone EJ. Detection of methadone, methadone metabolites, and other illicit drugs of abuse in hair of methadone-treatment subjects. J Anal Toxicol 1998;22:526-530.

42. Slawson MH, Wilkins DG, Foltz RL, Rollins DE. Quantitative determination of phencyclidine in pigmented and nonpigmented hair by ion-trap mass spectrometry. J Anal Toxicol 1996;20: 350-354.

43. Rollins DE, Wilkins DG, Krueger GG, Augsburger MP, Mizuno A, O'Neal C, et al. The effect of hair color on the incorporation of codeine into human hair. J Anal Toxicol 2003;27:545-551.

44. Schaffer M, Hill V, Cairns T. Hair analysis for cocaine: the requirement for effective wash procedures and effects of drug concentration and hair porosity in contamination and decontamination. J Anal Toxicol 2005;29:319-326.

45. Hoffman BH. Analysis of race effects on drug-test results. J Occup Environ Med 1999;41:612-624.

46. Kelly RC, Mieczkowski T, Sweeney SA, Bourland JA. Hair analysis for drugs of abuse. Hair color and race differentials or systematic differences in drug preferences? Forensic Sci Int 2000;107:63-86.

47. Blank DL, Kidwell DA. External contamination of hair by cocaine: an issue in forensic interpretation. Forensic Sci Int 1993;63:145-156; discussion 157-160.

48. Paulsen RB, Wilkins DG, Slawson MH, Shaw K, Rollins DE. Effect of four laboratory decontamination procedures on the quantitative determination of cocaine and metabolites in hair by HPLC-MS. J Anal Toxicol 2001;25:490-496.

49. Romano G, Barbera N, Lombardo I. Hair testing for drugs of abuse: evaluation of external cocaine contamination and risk of false positives. Forensic Sci Int 2001;123:119-129.

50. Cirimele V, Kintz P, Jamey C, Ludes B. Are cannabinoids detected in hair after washing with Cannabio shampoo? J Anal Toxicol 1999;23:349-351.

51. Uhl M, Sachs H. Cannabinoids in hair: strategy to prove marijuana/hashish consumption. Forensic Sci Int 2004;145:143-147.

52. Nakahara Y, Takahashi K, Sakamoto T, Tanaka A, Hill VA, Baumgartner WA. Hair analysis for drugs of abuse. XVII. Simultaneous detection of PCP, PCHP, and PCPdiol in human hair for confirmation of PCP use. J Anal Toxicol 1997;21:356-362.

53. Koren G, Klein J, Forman R, Graham K. Hair analysis of cocaine: differentiation between systemic exposure and external contamination. J Clin Pharmacol 1992;32:671-675.

54. Rohrich J, Zorntlein S, Potsch L, Skopp G, Becker J. Effect of the shampoo Ultra Clean on drug concentrations in human hair. Int J Legal Med 2000;113:102-106.

55. Walsh JM, Flegel R, Crouch DJ, Cangianelli L, Baudys J. An evaluation of rapid point-of-collection oral fluid drug-testing devices. J Anal Toxicol 2003;27:429-439.

56. Cone EJ, Presley L, Lehrer M, Seiter W, Smith M, Kardos KW, et al. Oral fluid testing for drugs of abuse: positive prevalence rates by intercept immunoassay screening and GC-MS-MS confirmation and suggested cutoff concentrations. J Anal Toxicol 2002;26:541-546.

57. Yacoubian GS, Jr., Wish ED, Perez DM. A comparison of saliva testing to urinalysis in an arrestee population. J Psychoactive Drugs 2001;33:289-294.

58. Laloup M, Tilman G, Maes V, De Boeck G, Wallemacq P, Ramaekers J, et al. Validation of an ELISA-based screening assay for the detection of amphetamine, MDMA and MDA in blood and oral fluid. Forensic Sci Int 2005;153:29-37.

59. Kankaanpaa A, Gunnar T, Ariniemi K, Lillsunde P, Mykkanen S, Seppala T. Single-step procedure for gas chromatography-mass spectrometry screening and quantitative determination of amphetamine-type stimulants and related drugs in blood, serum, oral fluid and urine samples. J Chromatogr B Analyt Technol Biomed Life Sci 2004;810:57-68.

60. Concheiro M, de Castro A, Quintela O, Lopez-Rivadulla M, Cruz A. Determination of MDMA, MDA, MDEA and MBDB in oral fluid using high performance liquid chromatography with native fluorescence detection. Forensic Sci Int 2005;150:221-226.

61. Mortier KA, Maudens KE, Lambert WE, Clauwaert KM, Van Bocxlaer JF, Deforce DL, et al. Simultaneous, quantitative determination of opiates, amphetamines, cocaine and benzoylecgonine in oral fluid by liquid chromatography quadrupole-time-of-flight mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2002;779:321-330.

62. Wood M, De Boeck G, Samyn N, Morris M, Cooper DP, Maes RA, et al. Development of a rapid and sensitive method for the quantitation of amphetamines in human plasma and oral fluid by LC-MS-MS. J Anal Toxicol 2003;27:78-87.

63. Gunnar T, Ariniemi K, Lillsunde P. Validated toxicological determination of 30 drugs of abuse as optimized derivatives in oral fluid by long column fast gas chromatography/electron impact mass spectrometry. J Mass Spectrom 2005;40:739-753.

64. Schepers RJ, Oyler JM, Joseph RE, Jr., Cone EJ, Moolchan ET, Huestis MA. Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers. Clin Chem 2003;49:121-132.

65. Maseda C, Hama K, Fukui Y, Matsubara K, Takahashi S, Akane A. Detection of delta 9-THC in saliva by capillary GC/ECD after marihuana smoking. Forensic Sci Int 1986;32:259-266.

66. Fucci N, De Giovanni N, Chiarotti M. Simultaneous detection of some drugs of abuse in saliva samples by SPME technique. Forensic Sci Int 2003;134:40-45.

67. Lo Muzio L, Falaschini S, Rappelli G, Bambini F, Baldoni A, Procaccini M, et al. Saliva as a diagnostic matrix for drug abuse. Int J Immunopathol Pharmacol 2005;18:567-573.

68. Niedbala RS, Kardos K, Fries T, Cannon A, Davis A. Immunoassay for detection of cocaine/metabolites in oral fluids. J Anal Toxicol 2001;25:62-68.

69. Campora P, Bermejo AM, Tabernero MJ, Fernandez P. Quantitation of cocaine and its major metabolites in human saliva using gas chromatography-positive chemical ionization-mass spectrometry (GC-PCI-MS). J Anal Toxicol 2003;27:270-274.

70. Yonamine M, Tawil N, Moreau RL, Silva OA. Solid-phase micro-extraction-gas chromatography-mass spectrometry and headspace-gas chromatography of tetrahydrocannabinol, amphetamine, methamphetamine, cocaine and ethanol in saliva samples. J Chromatogr B Analyt Technol Biomed Life Sci 2003;789:73-78.

71. Cognard E, Bouchonnet S, Staub C. Validation of a gas chromatography-ion trap tandem mass spectrometry for simultaneous analysis of cocaine and its metabolites in saliva. J Pharm Biomed Anal 2006;41:925-934.

72. Clauwaert K, Decaestecker T, Mortier K, Lambert W, Deforce D, Van Peteghem C, et al. The determination of cocaine, benzoylecgonine, and cocaethylene in small-volume oral fluid samples by liquid chromatography-quadrupole-time-of-flight mass spectrometry. J Anal Toxicol 2004;28:655-659.

73. Piekoszewski W, Janowska E, Stanaszek R, Pach J, Winnik L, Karakiewicz B, et al. Determination of opiates in serum, saliva and hair addicted persons. Przegl Lek 2001;58:287-289.

74. Speckl IM, Hallbach J, Guder WG, Meyer LV, Zilker T. Opiate detection in saliva and urine -a prospective comparison by gas chromatography-mass spectrometry. J Toxicol Clin Toxicol 1999;37:441-445.

75. Kidwell DA, Holland JC, Athanaselis S. Testing for drugs of abuse in saliva and sweat. J Chromatogr B Biomed Sci Appl 1998;713:111-135.

76. Broussard LA, Presley LC, Tanous M, Queen C. Improved gas chromatography-mass spectrometry method for simultaneous identification and quantification of opiates in urine as propionyl and oxime derivatives. Clin Chem 2001;47:127-129.

77. Singh J, Burke RE, Mertens LE. Elimination of the interferences by keto-opiates in the GC-MS analysis of 6-monoacetylmorphine. J Anal Toxicol 2000;24:27-31.

78. McCarron MM, Walberg CB, Soares JR, Gross SJ, Baselt RC. Detection of phencyclidine usage by radioimmunoassay of saliva. J Anal Toxicol 1984;8:197-201.

79. Wong RC, Tran M, Tung JK. Oral fluid drug tests: effects of adulterants and foodstuffs. Forensic Sci Int 2005;150:175-180.

80. Cooper G, Wilson L, Reid C, Baldwin D, Hand C, Spiehler V. Validation of the Cozart microplate EIA for analysis of opiates in oral fluid. Forensic Sci Int 2005;154:240-246.

81. Huestis MA, Oyler JM, Cone EJ, Wstadik AT, Schoendorfer D, Joseph RE, Jr. Sweat testing for cocaine, codeine and metabolites by gas chromatography-mass spectrometry. J Chromatogr B Biomed Sci Appl 1999;733:247-264.

82. Kacinko SL, Barnes AJ, Schwilke EW, Cone EJ, Moolchan ET, Huestis MA. Disposition of cocaine and its metabolites in human sweat after controlled cocaine administration. Clin Chem 2005;51:2085-2094.

83. Fogerson R, Schoendorfer D, Fay J, Spiehler V. Qualitative detection of opiates in sweat by EIA and GC-MS. J Anal Toxicol 1997;21:451-458.

84. Fay J, Fogerson R, Schoendorfer D, Niedbala RS, Spiehler V. Detection of methamphetamine in sweat by EIA and GC-MS. J Anal Toxicol 1996;20:398-403.

85. Samyn N, De Boeck G, Verstraete AG. The use of oral fluid and sweat wipes for the detection of drugs of abuse in drivers. J Forensic Sci 2002;47:1380-1387.

86. Samyn N, De Boeck G, Wood M, Lamers CT, De Waard D, Brookhuis KA, et al. Plasma, oral fluid and sweat wipe ecstasy concentrations in controlled and real life conditions. Forensic Sci Int 2002;128:90-97.

87. Saito T, Wtsadik A, Scheidweiler KB, Fortner N, Takeichi S, Huestis MA. Validated gas chromatographic-negative ion chemical ionization mass spectrometric method for delta(9)-tetrahydrocannabinol in sweat patches. Clin Chem 2004;50:2083-2090.

88. Kintz P, Cirimele V, Ludes B. Detection of cannabis in oral fluid (saliva) and forehead wipes (sweat) from impaired drivers. J Anal Toxicol 2000;24:557-561.

89. Liberty HJ, Johnson BD, Fortner N. Detecting cocaine use through sweat testing: multilevel modeling of sweat patch length-of-wear data. J Anal Toxicol 2004;28:667-673.

90. Perez-Reyes M, Di Guiseppi S, Brine DR, Smith H, Cook CE. Urine pH and phencyclidine excretion. Clin Pharmacol Ther 1982;32:635-641.

91. (accessed June 13, 2006). US Department of Health and Human Services. Office of applied studies. Pregnancy and Substance use Report.

92. Kwong TC, Ryan RM. Detection of intrauterine illicit drug exposure by newborn drug testing. National Academy of Clinical Biochemistry. Clin Chem 1997;43:235-242.

93. Ostrea EM, Jr., Brady M, Gause S, Raymundo AL, Stevens M. Drug screening of newborns by meconium analysis: a large-scale, prospective, epidemiologic study. Pediatrics 1992;89: 107-113.

94. Ostrea EM, Jr., Knapp DK, Tannenbaum L, Ostrea AR, Romero A, Salari V, et al. Estimates of illicit drug use during pregnancy by maternal interview, hair analysis, and meconium analysis. J Pediatr 2001;138:344-348.

95. Wingert WE, Feldman MS, Kim MH, Noble L, Hand I, Yoon JJ. A comparison of meconium, maternal urine and neonatal urine for detection of maternal drug use during pregnancy. J Forensic Sci 1994;39:150-158.

96. Lewis DE, Moore CM, Leikin JB, Koller A. Meconium analysis for cocaine: a validation study and comparison with paired urine analysis. J Anal Toxicol 1995;19:148-150.

97. Ostrea EM, Jr., Brady MJ, Parks PM, Asensio DC, Naluz A. Drug screening of meconium in infants of drug-dependent mothers: an alternative to urine testing. J Pediatr 1989;115:474-477.

98. Moore C, Negrusz A, Lewis D. Determination of drugs of abuse in meconium. J Chromatogr B Biomed Sci Appl 1998;713:137-146.

99. ElSohly MA, Kopycki W, Feng S, Murphy TP. Identification and analysis of the major metabolites of cocaine in meconium. J Anal Toxicol 1999;23:446-451.

100. ElSohly MA, Stanford DF, Murphy TP, Lester BM, Wright LL, Smeriglio VL, et al. Immunoassay and GC-MS procedures for the analysis of drugs of abuse in meconium. J Anal Toxicol 1999;23:436-445.

101. Bennett AD. Perinatal substance abuse and the drug-exposed neonate. Adv Nurse Pract 1999;7:32-36; quiz 37-38.

102. Xia Y, Wang P, Bartlett MG, Solomon HM, Busch KL. An LC-MS-MS method for the comprehensive analysis of cocaine and cocaine metabolites in meconium. Anal Chem 2000;72:764-771.

103. Bar-Oz B, Klein J, Karaskov T, Koren G. Comparison of meconium and neonatal hair analysis for detection of gestational exposure to drugs of abuse. Arch Dis Child Fetal Neonatal Ed 2003;88:F98-F100.

104. Montgomery D, Plate C, Alder SC, Jones M, Jones J, Christensen RD. Testing for fetal exposure to illicit drugs using umbilical cord tissue vs meconium. J Perinatol 2006;26:11-14.

105. Bibb KW, Stewart DL, Walker JR, Cook VD, Wagener RE. Drug screening in newborns and mothers using meconium samples, paired urine samples, and interviews. J Perinatol 1995;15:199-202.

106. Ryan RM, Wagner CL, Schultz JM, Varley J, DiPreta J, Sherer DM, et al. Meconium analysis for improved identification of infants exposed to cocaine in utero. J Pediatr 1994;125:435-440.

107. Moore C, Lewis D, Leikin J. False-positive and false-negative rates in meconium drug testing. Clin Chem 1995;41:1614-1616.

108. Pichini S, Pacifici R, Pellegrini M, Marchei E, Lozano J, Murillo J, et al. Development and validation of a high-performance liquid chromatography-mass spectrometry assay for determination of amphetamine, methamphetamine, and methylenedioxy derivatives in meconium. Anal Chem 2004;76:2124-2132.

109. Verma A, Dhanireddy R. Time of first stool in extremely low birth weight (< or = 1000 grams) infants. J Pediatr 1993;122:626-629.

110. Callahan CM, Grant TM, Phipps P, Clark G, Novack AH, Streissguth AP, et al. Measurement of gestational cocaine exposure: sensitivity of infants' hair, meconium, and urine. J Pediatr 1992;120:763-768.

111. Huestis MA, Cone WJ. Alternative testing matrices. In: Karch SB, ed. Drug Abuse Handbook: CRC Press, Boca Raton, FL 1998:799-858.

112. Boumba VA, Ziavrou KS, Vougiouklakis T. Hair as a biological indicator of drug use, drug abuse or chronic exposure to environmental toxicants. Int J Toxicol 2006;25:143-163.

113. Kintz P, Villain M, Cirimele V. Hair analysis for drug detection. Ther Drug Monit 2006;28:442-446.

Defeat Drugs Death

Defeat Drugs Death

This Book Is One Of The Most Valuable Resources In The World When It Comes To Helpful Info On Avoiding And Beating A Fatal Drug Addiction!

Get My Free Ebook

Post a comment